(19)

(11)

EP 4 532 493 A1

(12)

(43) Date of publication: 09.04.2025 Bulletin 2025/15 (21) Application number: 23734721.6 (22) Date of filing: 30.05.2023

(51) International Patent Classification (IPC):  C07D 417/14(2006.01) A61K 31/4436(2006.01) A61P 35/00(2006.01) (52) Cooperative Patent Classification (CPC): A61P 35/00; C07D 417/14 (86) International application number: PCT/IB2023/055539 (87) International publication number: WO 2023/233295 (07.12.2023 Gazette 2023/49)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 01.06.2022 US 202263365628 P (71) Applicants: Ideaya Biosciences, Inc. South San Francisco, California 94080 (US) GlaxoSmithKline Intellectual Property (No.4) Limited Stevenage SG1 2NY (GB)

(72) Inventors: ADAMS, Nicholas Collegeville, Pennsylvania 19426 (US) BOTYANSZKI, Janos Collegeville, Pennsylvania 19426 (US) DUFFY, Kevin Collegeville, Pennsylvania 19426 (US) WANG, Chenbo San Francisco, California 94080 (US) FISCHER, Marcus Michael san francisco, California 94080 (US) MASKEY, Reeja San Francisco, California 94080 (US) (74) Representative: Coggins, Julia Frances  GSK Legal & Compliance - Global Patents 79 New Oxford Street London WC1A 1DG London WC1A 1DG (GB)